Payment overview · 2025
General Payments
$104.77
4 reported records · 2 companies
Healthcare provider profile · identity verified
Jephte Rodriguez Martinez, M.D.
Allopathic & Osteopathic Physicians|General Practice · MAYAGUEZ, PR · NPI 1023190071
Verified facts
What the public records show
CMS Open Payments records show Jephte Rodriguez Martinez, M.D. received $104.77 in general payments during 2025 across 4 reported records.
AstraZeneca Pharmaceuticals LP accounted for 75.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 108 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $78.76 | 75.2% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $26.01 | 24.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $104.77 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $78.76 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $26.01 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
108 | 30 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
22 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Famotidine | Famotidine | 844 | 165 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 479 | 149 |
| Gabapentin | Gabapentin | 456 | 121 |
| Atorvastatin Calcium | Atorvastatin Calcium | 455 | 142 |
| Losartan Potassium | Losartan Potassium | 449 | 126 |
| Simvastatin | Simvastatin | 414 | 118 |
| Omeprazole | Omeprazole | 399 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 376 | 107 |
| Clonazepam | Clonazepam | 307 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 306 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 298 | 89 |
| Metformin Hcl | Metformin Hcl | 293 | 89 |
| Dexamethasone | Dexamethasone | 256 | 134 |
| Temazepam | Temazepam | 249 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 242 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 233 | 50 |
| Alendronate Sodium | Alendronate Sodium | 219 | 63 |
| Ezetimibe | Ezetimibe | 219 | 70 |
| Synthroid | Levothyroxine Sodium | 219 | 69 |
| Montelukast Sodium | Montelukast Sodium | 211 | 55 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 210 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 207 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 203 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 200 | 64 |
| Nabumetone | Nabumetone | 196 | 75 |
| Glimepiride | Glimepiride | 173 | 59 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 171 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 167 | 37 |
| Mupirocin | Mupirocin | 165 | 67 |
| Azithromycin | Azithromycin | 163 | 128 |
| Alprazolam | Alprazolam | 158 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 153 | 38 |
| Lisinopril | Lisinopril | 148 | 42 |
| Trazodone Hcl | Trazodone Hcl | 148 | 40 |
| Methotrexate | Methotrexate Sodium | 141 | 23 |
| Levofloxacin | Levofloxacin | 136 | 92 |
| Baclofen | Baclofen | 131 | 47 |
| Memantine Hcl | Memantine Hcl | 126 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 125 | 45 |
| Latanoprost | Latanoprost | 125 | 20 |
| Enalapril Maleate | Enalapril Maleate | 124 | 38 |
| Sertraline Hcl | Sertraline Hcl | 119 | 30 |
| Candesartan Cilexetil | Candesartan Cilexetil | 110 | 33 |
| Farxiga | Dapagliflozin Propanediol | 108 | 30 |
| Carvedilol | Carvedilol | 104 | 33 |
| Furosemide | Furosemide | 104 | 37 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 102 | 84 |
| Doxazosin Mesylate | Doxazosin Mesylate | 102 | 29 |
| Donepezil Hcl | Donepezil Hcl | 97 | 24 |
| Allopurinol | Allopurinol | 86 | 17 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 86 | 22 |
| Finasteride | Finasteride | 83 | 24 |
| Cilostazol | Cilostazol | 77 | 21 |
| Mometasone Furoate | Mometasone Furoate | 77 | 20 |
| Clindamycin Hcl | Clindamycin Hcl | 75 | 58 |
| Metoclopramide Hcl | Metoclopramide Hcl | 75 | 19 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 73 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 21 |
| Glipizide | Glipizide | 71 | 21 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 71 | 24 |
| Celecoxib | Celecoxib | 69 | 24 |
| Sucralfate | Sucralfate | 68 | 13 |
| Lorazepam | Lorazepam | 67 | suppressed |
| Xarelto | Rivaroxaban | 67 | 21 |
| Etodolac | Etodolac | 66 | 28 |
| Irbesartan | Irbesartan | 66 | 20 |
| Tramadol Hcl | Tramadol Hcl | 65 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 63 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 62 | 20 |
| Ciclopirox | Ciclopirox | 61 | 16 |
| Prednisone | Prednisone | 59 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 58 | suppressed |
| Eliquis | Apixaban | 56 | 15 |
| Januvia | Sitagliptin Phosphate | 56 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 15 |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 53 | 15 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 53 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 52 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 50 | 14 |
| Clotrimazole | Clotrimazole | 48 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 15 |
| Lactulose | Lactulose | 44 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 43 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 43 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Trulicity | Dulaglutide | 40 | suppressed |
| Levoxyl | Levothyroxine Sodium | 36 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 36 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | 12 |
| Divalproex Sodium | Divalproex Sodium | 34 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 34 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | 11 |
| Meloxicam | Meloxicam | 33 | 16 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 33 | 11 |
| Buspirone Hcl | Buspirone Hcl | 32 | 12 |
| Colchicine | Colchicine | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Tobramycin | Tobramycin | 32 | 13 |
| Atenolol | Atenolol | 31 | suppressed |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | 13 |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 31 | suppressed |
| Pentoxifylline | Pentoxifylline | 30 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Galantamine Er | Galantamine Hbr | 29 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 28 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 28 | 28 |
| Spironolactone | Spironolactone | 28 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Anastrozole | Anastrozole | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 24 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 17 |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | 12 |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Humalog | Insulin Lispro | 20 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 20 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Humalog Mix 50-50 Kwikpen | Insulin Lispro Protamin/Lispro | 18 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 17 | suppressed |
| Etodolac Er | Etodolac | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Sulindac | Sulindac | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Fluconazole | Fluconazole | 16 | 13 |
| Indapamide | Indapamide | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 15 | suppressed |
| Fluocinonide | Fluocinonide | 15 | suppressed |
| Hydroxyurea | Hydroxyurea | 15 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 13 |
| Acyclovir | Acyclovir | 14 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 14 | suppressed |
| Humulin R | Insulin Regular, Human | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Procto-Med Hc | Hydrocortisone | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | 11 |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Cetirizine Hcl | Cetirizine Hcl | 13 | 12 |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 13 | suppressed |
| Estazolam | Estazolam | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Hydrocortisone-Pramoxine | Hydrocortisone/Pramoxine | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Pentips Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $104.77 · 4 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, Cologuard Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error